Product Description
Overall, the global direct restorative material market was valued at nearly $2.2 billion in 2022. This is expected to increase over the forecast period at a CAGR of 4.0% to reach $2.9 billion.
The full report suite on the global market for direct restorative materials includes composite, glass ionomer (GI) and resin-modified GI (RMGI) as well as amalgam material segments. The number of direct restorative procedures is similarly divided into procedures performed with composite, GI/RMGI and amalgam.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2029, and Historical Data to 2019
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Procedure Volumes
- Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL DIRECT RESTORATIVE MATERIAL MARKET INSIGHTS
Composite materials constituted the largest segment of the direct restorative material market in 2022, by far, and they will increase their share of the overall market by the end of the forecast period.
The aesthetic disadvantage of amalgam materials and the favorability of alternatives have thwarted the growth of the amalgam market, as reflected in its anticipated decline over the forecast period. The waning of amalgam will be largely driven by decreases in unit sales, which
also reflects the drop in the material’s share of the direct restorative market value over the forecast period.
GLOBAL DIRECT RESTORATIVE MATERIAL MARKET SHARE INSIGHTS
Within the global market for Direct Restorative Material, there are three key market players – 3M, Dentsply Sirona and Kerr.
In 2022, 3M led the global direct restorative material market by capturing the top position in the composites market segment, while also holding a strong share in the GI/RMGI market segments. Their signature product, the Filtek™ composite material, is well-known for its durability and longevity. Dentsply Sirona and Kerr closely follow 3M in this market with their own high-quality products.
MARKET SEGMENTATION SUMMARY
- Direct Restorative Material Market – MedCore – The analysis dives deep into segmentation by:
- Product Type: Composites, Glass Ionomer/Resin Ionomer, and Amalgam;
- Delivery Type: Powder/Liquid, Two-Paste/Syringe, Unit Dose/Capsules, Auto-Mix Syringe;
- Curing Method: Light-Cure, Self-Cure, and Dual-Cure;
- Viscosity: Low Viscosity, Regular Viscosity, and High Viscosity.
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regional Coverage | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavor never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
